Hanes V - Search Results

1

Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.

Diem S, Grady D, Quan J, Vittinghoff E, Wallace R, Hanes V, Ensrud K. Diem S, et al. Among authors: hanes v. Menopause. 2006 Jan-Feb;13(1):130-8. doi: 10.1097/01.gme.0000192439.82491.24. Menopause. 2006. PMID: 16607109 Clinical Trial.

2

Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women.

Grady D, Vittinghoff E, Lin F, Hanes V, Ensrud K, Habel LA, Wallace R, Macer J, Cummings SR, Shepherd J. Grady D, et al. Among authors: hanes v. Menopause. 2007 May-Jun;14(3 Pt 1):391-6. doi: 10.1097/01.gme.0000236939.81819.6c. Menopause. 2007. PMID: 17224859 Clinical Trial.

3

Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.

Yaffe K, Vittinghoff E, Ensrud KE, Johnson KC, Diem S, Hanes V, Grady D. Yaffe K, et al. Among authors: hanes v. Arch Neurol. 2006 Jul;63(7):945-50. doi: 10.1001/archneur.63.7.945. Arch Neurol. 2006. PMID: 16831962 Clinical Trial.

4

The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women.

Huang A, Yaffe K, Vittinghoff E, Kuppermann M, Addis I, Hanes V, Quan J, Grady D. Huang A, et al. Among authors: hanes v. Am J Obstet Gynecol. 2008 Mar;198(3):265.e1-7. doi: 10.1016/j.ajog.2007.09.039. Am J Obstet Gynecol. 2008. PMID: 18313446 Clinical Trial.

5

Comparison of methods to measure low serum estradiol levels in postmenopausal women.

Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, Chandler W, Settlage J, Beattie MS, Folkerd E, Dowsett M, Grady D, Cummings SR. Lee JS, et al. Among authors: hanes v. J Clin Endocrinol Metab. 2006 Oct;91(10):3791-7. doi: 10.1210/jc.2005-2378. Epub 2006 Aug 1. J Clin Endocrinol Metab. 2006. PMID: 16882749

6

Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.

Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH. Preston RA, et al. Among authors: hanes v. Menopause. 2007 May-Jun;14(3 Pt 1):408-14. doi: 10.1097/01.gme.0000243572.63322.f7. Menopause. 2007. PMID: 17224857 Clinical Trial.

7

Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.

Archer DF, Thorneycroft IH, Foegh M, Hanes V, Glant MD, Bitterman P, Kempson RL. Archer DF, et al. Among authors: hanes v. Menopause. 2005 Nov-Dec;12(6):716-27. doi: 10.1097/01.gme.0000177318.24005.b1. Epub 2005 Nov 8. Menopause. 2005. PMID: 16278615 Clinical Trial.

8

Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.

Simon JA, Kingsberg SA, Shumel B, Hanes V, Garcia M Jr, Sand M. Simon JA, et al. Among authors: hanes v. Menopause. 2014 Jun;21(6):633-40. doi: 10.1097/GME.0000000000000134. Menopause. 2014. PMID: 24281236 Clinical Trial.

9

Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.

White WB, Hanes V, Chauhan V, Pitt B. White WB, et al. Among authors: hanes v. Hypertension. 2006 Aug;48(2):246-53. doi: 10.1161/01.HYP.0000232179.60442.84. Epub 2006 Jun 26. Hypertension. 2006. PMID: 16801478 Clinical Trial.

10

Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.

White WB, Pitt B, Preston RA, Hanes V. White WB, et al. Among authors: hanes v. Circulation. 2005 Sep 27;112(13):1979-84. doi: 10.1161/CIRCULATIONAHA.104.501502. Circulation. 2005. PMID: 16186434 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters